S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
US Dollar Replaced By "Biden Bucks"? (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
US Dollar Replaced By "Biden Bucks"? (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Here’s How the Inflation Reduction Act Energizes Power Stock
Average US gasoline price falls 45 cents to $4.10 per gallon
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
US Dollar Replaced By "Biden Bucks"? (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
US Dollar Replaced By "Biden Bucks"? (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Here’s How the Inflation Reduction Act Energizes Power Stock
Average US gasoline price falls 45 cents to $4.10 per gallon
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
US Dollar Replaced By "Biden Bucks"? (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
US Dollar Replaced By "Biden Bucks"? (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Here’s How the Inflation Reduction Act Energizes Power Stock
Average US gasoline price falls 45 cents to $4.10 per gallon
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Is AMC Entertainment Pulling a Fast One on the APEs?
US Dollar Replaced By "Biden Bucks"? (Ad)
Boredom, loneliness plague Ukrainian youth near front line
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
High oil prices help Saudi Aramco earn $88B in first half
US Dollar Replaced By "Biden Bucks"? (Ad)
Ship carrying grain for hungry Ethiopia leaves Ukraine
Here’s How the Inflation Reduction Act Energizes Power Stock
Average US gasoline price falls 45 cents to $4.10 per gallon
Sell every Stock except ONE (Ad)
NASDAQ:CSII

Cardiovascular Systems - CSII Stock Forecast, Price & News

$16.64
+0.35 (+2.15%)
(As of 08/12/2022 09:14 PM ET)
Add
Compare
Today's Range
$16.25
$16.75
50-Day Range
$13.53
$16.71
52-Week Range
$13.41
$38.52
Volume
177,600 shs
Average Volume
366,811 shs
Market Capitalization
$678.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$36.33

Cardiovascular Systems MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
118.3% Upside
$36.33 Price Target
Short Interest
Bearish
4.32% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
0.20mentions of Cardiovascular Systems in the last 14 days
Based on 17 Articles This Week
Insider Trading
Acquiring Shares
$43,500 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.68) to ($0.51) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

558th out of 1,135 stocks

Surgical & Medical Instruments Industry

53rd out of 114 stocks

CSII stock logo

About Cardiovascular Systems (NASDAQ:CSII) Stock

Cardiovascular Systems, Inc., a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company has a partnership with Chansu Vascular Technologies, LLC to develop peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.

Cardiovascular Systems Trading Up 2.1 %

CSII traded up $0.35 during midday trading on Friday, reaching $16.64. 177,636 shares of the company's stock were exchanged, compared to its average volume of 291,714. The business has a 50-day simple moving average of $15.20 and a two-hundred day simple moving average of $17.76. The company has a quick ratio of 5.19, a current ratio of 6.05 and a debt-to-equity ratio of 0.08. Cardiovascular Systems has a one year low of $13.41 and a one year high of $38.52.

Insider Transactions at Cardiovascular Systems

In other news, CFO Jeffrey S. Points acquired 3,000 shares of the company's stock in a transaction dated Friday, May 20th. The stock was bought at an average price of $14.50 per share, with a total value of $43,500.00. Following the completion of the acquisition, the chief financial officer now owns 109,312 shares in the company, valued at approximately $1,585,024. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 3.00% of the company's stock.

Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

CSII Stock News Headlines

Cardiovascular Systems, Inc. (CSII)
Cardiovascular Systems Tops Q3 EPS by 3c
Cardiovascular Systems Q3 2022 Earnings Preview
See More Headlines
Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

CSII Company Calendar

Last Earnings
11/08/2021
Today
8/15/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:CSII
CUSIP
14161910
Employees
780
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$36.33
High Stock Price Forecast
$49.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+118.3%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$-36,930,000.00
Pretax Margin
-15.50%

Debt

Sales & Book Value

Annual Sales
$236.22 million
Book Value
$6.12 per share

Miscellaneous

Free Float
39,561,000
Market Cap
$678.66 million
Optionable
Optionable
Beta
0.94

Social Links


Key Executives

  • Mr. Scott Raymond Ward B.Sc. (Age 62)
    M.S., MS, Chairman, Pres & CEO
    Comp: $1.46M
  • Mr. Jeffrey S. Points (Age 45)
    Chief Financial Officer
    Comp: $682.69k
  • Mr. Alexander Rosenstein (Age 50)
    Gen. Counsel & Corp. Sec.
    Comp: $614.96k
  • Mr. John M. Hastings (Age 42)
    Exec. VP of Operations & Technology
  • Mr. John E. Nielsen
    VP of Investor Relations & Corp. Communications
  • Ms. Sandra M. Sedo (Age 58)
    Chief Compliance Officer
  • Mr. Stephen J. Rempe (Age 49)
    Chief HR Officer
  • Dr. Jeffrey W. Chambers M.D.
    Chief Medical Officer













CSII Stock - Frequently Asked Questions

Should I buy or sell Cardiovascular Systems stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CSII shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CSII, but not buy additional shares or sell existing shares.
View CSII analyst ratings
or view top-rated stocks.

What is Cardiovascular Systems' stock price forecast for 2022?

5 equities research analysts have issued 1 year target prices for Cardiovascular Systems' shares. Their CSII share price forecasts range from $20.00 to $49.00. On average, they expect the company's stock price to reach $36.33 in the next year. This suggests a possible upside of 118.3% from the stock's current price.
View analysts price targets for CSII
or view top-rated stocks among Wall Street analysts.

How have CSII shares performed in 2022?

Cardiovascular Systems' stock was trading at $18.78 at the start of the year. Since then, CSII shares have decreased by 11.4% and is now trading at $16.64.
View the best growth stocks for 2022 here
.

When is Cardiovascular Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our CSII earnings forecast
.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings results on Monday, November, 8th. The medical device company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.12. The medical device company earned $58.40 million during the quarter, compared to the consensus estimate of $63.72 million. Cardiovascular Systems had a negative net margin of 15.64% and a negative trailing twelve-month return on equity of 14.40%. Cardiovascular Systems's quarterly revenue was down 3.5% on a year-over-year basis. During the same quarter last year, the business posted ($0.05) EPS.

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems updated its FY 2023 earnings guidance on Wednesday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $255.00 million-$265.00 million, compared to the consensus revenue estimate of $236.73 million.

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

12 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), Xcel Energy (XEL), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (2.31%), Assenagon Asset Management S.A. (2.11%), Northern Trust Corp (1.06%), JPMorgan Chase & Co. (0.90%), Principal Financial Group Inc. (0.68%) and BNP Paribas Arbitrage SA (0.46%). Insiders that own company stock include Alexander Rosenstein, Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb, Sandra Sedo and Scott R Ward.
View institutional ownership trends
.

How do I buy shares of Cardiovascular Systems?

Shares of CSII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $16.64.

How much money does Cardiovascular Systems make?

Cardiovascular Systems (NASDAQ:CSII) has a market capitalization of $678.58 million and generates $236.22 million in revenue each year. The medical device company earns $-36,930,000.00 in net income (profit) each year or ($0.95) on an earnings per share basis.

How many employees does Cardiovascular Systems have?

The company employs 780 workers across the globe.

When was Cardiovascular Systems founded?

Cardiovascular Systems was founded in 1989.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The official website for the company is www.csi360.com. The medical device company can be reached via phone at (651) 259-1600, via email at j.nielsen@csi360.com, or via fax at 612-677-3355.

This page (NASDAQ:CSII) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.